Endocyte, Inc. (ECYT) To Present At Upcoming Conferences
2/7/2014 9:03:22 AM
WEST LAFAYETTE, Ind., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that the company's management team will present at the following upcoming investment conferences in February:
Help employers find you! Check out all the jobs and post your resume.
comments powered by